Carrier immunoglobulins
US9562108B2 · kind B2 · utility
8Cited by
5References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 2014 |
| Grant date | Feb 7, 2017 |
| Priority date | — |
| Expiry date | Feb 19, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is an isolated antigen binding protein, such as but not limited to, an antibody or antibody fragment. Also disclosed are pharmaceutical compositions and medicaments comprising the antigen binding protein, isolated nucleic acid encoding it, vectors, host cells, and hybridomas useful in methods of making it. In some embodiments the antigen binding protein comprises one to twenty-four pharmacologically active chemical moieties conjugated thereto, such as a pharmacologically active polypeptide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.